The intravenous (IV) fluid bags market in the world is estimated to reach USD 3.01 billion in 2026 and is projected to grow at a CAGR of 6.8% between 2026 and 2035 to a size of around USD 5.46 billion.
Intravenous (IV) Fluid Bags Market Revenue and Trends
The intravenous (IV) fluid bag market is a global market offering sterile and flexible containers where hydration fluids, electrolytes, medications, parenteral nutrition and blood products could be safely delivered in hospitals, clinics, ambulatory facilities and home care.
The IV fluid bags market has been increasing at a significant rate, owing to the rise in the number of chronic diseases, the increase in surgical and trauma cases, the rise in the elderly population that requires IV fluids, the growth of home care and ambulatory care, and the development of non-PVC, multi-chamber, and ready-to-use IV fluid bags in the healthcare ecosystems across the world.
%20Fluid%20Bags%20Market%20Size%20%20%202025%20to%202035%20(USD%20Billion).png)
What are the Factors That Have a Significant Contribution to the Growth of the intravenous (IV) fluid bags market?
The growing number of cases of dehydration, chronic illnesses (diabetes, cancer, kidney disease), malnutrition, and post-operative recovery requirements created by the aging demographics, lifestyle diseases, increasing divorce/surgical rates, has increased the demand of IV fluid bag products. With the increasing access to healthcare and outpatient/home based infusion services around the globe, an increased number of patients will be in need of a competent, sterile IV delivery system to provide fluid replacement, medication delivery, and nutrition.
Technological innovations have brought about the introduction of safer patient safety such as non-PVC/DEHP-free, multi-chamber bags to allow stable mixing of products, ready-to-use (RTU) premixed solutions, eco-friendly and recyclable designing, and smart/connected to help enhance sterility, minimise waste and improve adherence. The other contributory factors are the increased attention to infection control and sustainability, expanded reimbursement of home infusion, the government-sustained healthcare infrastructure and emergency preparedness programs in developed and emerging regions.
Segment Insight
By Product Type
As of 2025, with a substantial proportion of intravenous (IV) fluid bags sold by large volumes of hospitals and home care criminalizing non-PVC IV fluid bags controlled the largest share of the non-PVC IV fluid bags market, due to its high popularity in hospitals and home care due to its superior safety profile (no phthalate leaching), environmental friendliness, and compatibility with sensitive medications, further development of flexible, recyclable, and multi-chamber non-PVC designs was identified by large numbers of clinicians and pharmacists as the best way of reducing patient risk and supporting sustainable healthcare practices.
By Distribution Channel
The most significant market share can be found in hospitals and ambulatory surgical centers which are the major location of bulk purchasing, sterile storage, and high usage of IV fluid bags in acute care, surgical, and emergency units. These channels have been the choice of delivering intravenous fluid bags because they offer professional knowledge on fluid selection, compatibility checks and administration protocols in the high-acuity settings.
Regional Insights
With good healthcare services infrastructure, a high chronic disease burden, high regulations standards supporting non-PVC substitutes, and a broad usage of home-infusion electronic devices, the North American market controls the entire market of intravenous (IV) fluid bags in the world. North America is advantageous too with powerful reimbursement policies, existence of major manufacturers and incorporation of environment-friendly and ready-to-use solutions at an earlier stage. The increased concentration of the key players in the industries and constant innovation as well as large volumes of surgical procedures enhance the continued dominative position of North America.
Moreover, the Asia Pacific market is registering the best growth rate in the intravenous (IV) fluid bags market due to its big population, growing healthcare spending, the growth in surgical surgeries, the expanded growth of hospitals and home care facilities, and the increased interest in the management of chronic diseases. The adoption of IV fluid bags has been observed to increase notably in the countries of China, India and Japan as the affordability has been on the rise, the infrastructure has grown and the access to healthcare modernization and emergency programs is supported by the government. This region will experience the rapid growth of the market in Asia Pacific as a result of the acceleration of medical tourism, the development of the number of private hospitals, and outpatient care.
Report Scope
Feature of the Report | Details |
Market Size in 2026 | USD 3.01 billion |
Projected Market Size in 2035 | USD 5.46 billion |
Market Size in 2025 | USD 2.82 billion |
CAGR Growth Rate | 6.8% CAGR |
Base Year | 2025 |
Forecast Period | 2026-2035 |
Key Segment | By Material Type, Chamber Type, Capacity, Application, End-User and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Recent Developments
In December 2025: Baxter expanded its ready-to-use IV portfolio with new multi-chamber non-PVC bags featuring enhanced stability for parenteral nutrition and critical care fluids, improving safety and reducing preparation time in hospital and home settings.
List of the prominent players in the Intravenous (IV) Fluid Bags Market:
Baxter International Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
ICU Medical Inc.
Pfizer Inc.
Grifols S.A.
JW Life Science Corporation
Technoflex
Sippex IV Bag
Renolit SE
Others
The Intravenous (IV) Fluid Bags Market is segmented as follows:
By Material Type
PVC Bags
o DEHP-containing PVC
o DEHP-free PVC
Non-PVC Bags
o Polyolefin Bags
o EVA Bags
o Polypropylene Bags
Glass Bottles
By Chamber Type
Single-Chamber Bags
Multi-Chamber Bags
o Two-Chamber Bags
o Three-Chamber Bags
By Capacity
50-100 ml
100-250 ml
250-500 ml
500-1000 ml
Above 1000 ml
By Application
Fluid Therapy
o Hydration
o Electrolyte Balance
Nutrition Therapy
o Parenteral Nutrition
o Total Parenteral Nutrition (TPN)
Drug Administration
o Antibiotics
o Chemotherapy
o Pain Management
Blood & Blood Products
Other Applications
By End-User
Hospitals
o General Hospitals
o Specialty Hospitals
Ambulatory Surgical Centers
Home Healthcare
Clinics
Others
Regional Coverage:
North America
U.S.
Canada
Mexico
Rest of North America
Europe
Germany
France
U.K.
Russia
Italy
Spain
Netherlands
Rest of Europe
Asia Pacific
China
Japan
India
New Zealand
Australia
South Korea
Taiwan
Rest of Asia Pacific
The Middle East & Africa
Saudi Arabia
UAE
Egypt
Kuwait
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
